PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,491,211 | -14.9% | 45,816 | -14.5% | 1.22% | -5.0% |
| Q2 2023 | $7,623,296 | +11.0% | 53,572 | 0.0% | 1.29% | +16.5% |
| Q1 2023 | $6,869,538 | +6.6% | 53,572 | -0.2% | 1.11% | +16.4% |
| Q4 2022 | $6,442,427 | +14.8% | 53,669 | 0.0% | 0.95% | -3.5% |
| Q3 2022 | $5,614,000 | -1.6% | 53,669 | 0.0% | 0.98% | -3.0% |
| Q2 2022 | $5,707,000 | -1.3% | 53,669 | 0.0% | 1.01% | +7.4% |
| Q1 2022 | $5,781,000 | -33.8% | 53,669 | -25.5% | 0.94% | -24.6% |
| Q4 2021 | $8,728,000 | +1.1% | 72,042 | -0.1% | 1.25% | -12.1% |
| Q3 2021 | $8,637,000 | -15.2% | 72,105 | 0.0% | 1.42% | -12.1% |
| Q2 2021 | $10,186,000 | +2.6% | 72,105 | 0.0% | 1.62% | -21.7% |
| Q1 2021 | $9,925,000 | -7.8% | 72,105 | -19.9% | 2.07% | -27.4% |
| Q4 2020 | $10,766,000 | – | 90,011 | – | 2.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |